These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25996060)

  • 1. How has the genomics era impacted schistosomiasis drug discovery?
    Oliveira G; Pierce RJ
    Future Med Chem; 2015; 7(6):685-7. PubMed ID: 25996060
    [No Abstract]   [Full Text] [Related]  

  • 2. Target-based molecular modeling strategies for schistosomiasis drug discovery.
    Ferreira LG; Oliva G; Andricopulo AD
    Future Med Chem; 2015; 7(6):753-64. PubMed ID: 25996068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma comparative genomics: integrating genome structure, parasite biology and anthelmintic discovery.
    Swain MT; Larkin DM; Caffrey CR; Davies SJ; Loukas A; Skelly PJ; Hoffmann KF
    Trends Parasitol; 2011 Dec; 27(12):555-64. PubMed ID: 22024648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosome sirtuins as drug targets.
    Lancelot J; Cabezas-Cruz A; Caby S; Marek M; Schultz J; Romier C; Sippl W; Jung M; Pierce RJ
    Future Med Chem; 2015; 7(6):765-82. PubMed ID: 25996069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the mechanism of action of praziquantel and how might resistance strike?
    Cupit PM; Cunningham C
    Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
    [No Abstract]   [Full Text] [Related]  

  • 6. Using an open source model to accelerate schistosomiasis drug research.
    Todd MH; Coaker H
    Future Med Chem; 2015; 7(6):689-92. PubMed ID: 25996061
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives.
    Marek M; Oliveira G; Pierce RJ; Jung M; Sippl W; Romier C
    Future Med Chem; 2015; 7(6):783-800. PubMed ID: 25996070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosomiasis and its treatment.
    Caffrey CR
    Future Med Chem; 2015; 7(6):675-6. PubMed ID: 25996057
    [No Abstract]   [Full Text] [Related]  

  • 9. [Research progress of the evaluation methods on the resistance of schistosome to praziquantel].
    Guo J; Guo JG
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):182-4. PubMed ID: 16300016
    [No Abstract]   [Full Text] [Related]  

  • 10. Apoptosis in schistosomes: toward novel targets for the treatment of schistosomiasis.
    Lee EF; Young ND; Lim NT; Gasser RB; Fairlie WD
    Trends Parasitol; 2014 Feb; 30(2):75-84. PubMed ID: 24393571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in Schistosoma genomics.
    Mourão MM; Grunau C; LoVerde PT; Jones MK; Oliveira G
    Parasite Immunol; 2012; 34(2-3):151-62. PubMed ID: 22145587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Progress on the Genomics of Schistosomiasis for Drug Discovery and Diagnostics.
    Meghani N; Lee BJ; Amin H; Nili-Ahmadabadi B; Nagendran S
    Infect Disord Drug Targets; 2020; 20(5):598-610. PubMed ID: 31613729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis.
    Lee EF; Fairlie WD
    Future Med Chem; 2015; 7(6):707-11. PubMed ID: 25996064
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug discovery: schistosome treatment.
    Shadan S
    Nature; 2008 Mar; 452(7185):296. PubMed ID: 18354470
    [No Abstract]   [Full Text] [Related]  

  • 15. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: is actin the praziquantel receptor?
    Tallima H; El Ridi R
    Int J Antimicrob Agents; 2007 Dec; 30(6):566-7. PubMed ID: 17900872
    [No Abstract]   [Full Text] [Related]  

  • 17. Decades down the line: the viability of praziquantel for future schistosomiasis treatment.
    Cioli D; Basso A; Valle C; Pica-Mattoccia L
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):835-7. PubMed ID: 23030319
    [No Abstract]   [Full Text] [Related]  

  • 18. Praziquantel: do we need another antischistosoma treatment?
    Fenwick A
    Future Med Chem; 2015; 7(6):677-80. PubMed ID: 25996058
    [No Abstract]   [Full Text] [Related]  

  • 19. Antischistosomal agents: state of art and perspectives.
    Lago EM; Xavier RP; Teixeira TR; Silva LM; da Silva Filho AA; de Moraes J
    Future Med Chem; 2018 Jan; 10(1):89-120. PubMed ID: 29235368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycolytic activities of Schistosoma mansoni and the mode of action of antischistosomal drugs (Ambilhar and Astiban).
    Magzoub M; Maegraith BG
    Ann Trop Med Parasitol; 1969 Sep; 63(3):377-91. PubMed ID: 5373668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.